GSK plc Cash And Cash Equivalents
GSK plc (GLAXF) had Cash And Cash Equivalents of GBP 3.40 billion as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-06
- 2025-12-31: Cash And Cash Equivalents 3.40B GBP.
- 2024-12-31: Cash And Cash Equivalents 3.87B GBP.
- 2023-12-31: Cash And Cash Equivalents 2.94B GBP.
- 2022-12-31: Cash And Cash Equivalents 3.72B GBP.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | 3.40B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 3.87B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 2.94B GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 3.72B GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 4.27B GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 6.29B GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 4.71B GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 3.87B GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 3.83B GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 4.90B GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 5.83B GBP 20-F/A · filed 2018-03-20 |